Aino Launonen

Use of the Levonorgestrel-Releasing Intrauterine System and Breast Cancer

Tiina Backman, Ilkka Rauramo, Kimmo Jaakkola et al. · Obstetrics and Gynecology · 2005 · 156 citations

Medicine, Endocrinology, Oncology +16

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

John F. Seymour, Robert Marcus, Andrew Davies et al. · Haematologica · 2018 · 112 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women

Sibylle P. Hämmerle, Linda Mindeholm, Aino Launonen et al. · Bone · 2012 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +11

No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study

Laurie H. Sehn, Angela Giovanna Congiu, Dominic Culligan et al. · Blood · 2018 · 28 citations

Medicine, Oncology, Hematologic Oncology +4

Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study

Carla Casulo, Michael Herold, Wolfgang Hiddemann et al. · Clinical Lymphoma Myeloma & Leukemia · 2022 · 24 citations

Medicine, Oncology, Pathology +14